Enhanced persistence with tiotropium compared with other respiratory drugs in COPD

Respiratory Medicine

Volumn 101, Issue 7, 2007, Pages 1398-1405

  Breekveldt Postma, Nancy S ^a   Koerselman, Jeroen ^a   Erkens, Joëlle A ^a   Lammers, Jan Willem J ^b   Herings, Ron M C ^a,c  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Adherence; Chronic obstructive pulmonary disease; Inhalation therapy; Persistence; Tiotropium

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; EXPECTORANT AGENT; IPRATROPIUM BROMIDE; LONG ACTING DRUG; MUCOLYTIC AGENT; SHORT ACTING DRUG; TIOTROPIUM BROMIDE; XANTHINE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NETHERLANDS; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; AGED; BRONCHODILATOR AGENTS; COHORT STUDIES; DATABASES; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IPRATROPIUM; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PATIENT COMPLIANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCOPOLAMINE DERIVATIVES; TREATMENT OUTCOME;

EID: 34249720153     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.01.025     Document Type: Article

References (31)

1. Chronic obstructive pulmonary disease. [Data fact sheet] 2003 [cited 2006 February 28]; Available from: 〈http://www.nhlbi.nih.gov/health/public/lung/other/copd_fact.pdf〉.
2. Currie G.P., Rossiter C., Miles S.A., Lee D.K., and Dempsey O.J. Effects of tiotropium and other long acting bronchodilators in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 19 2 (2006) 112-119
3. Tashkin D.P. Is a long-acting inhaled bronchodilator the first agent to use in stable chronic obstructive pulmonary disease?. Curr Opinion Pulm Med 11 2 (2005) 121-128
4. Cooper C.B., and Tashkin D.P. Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease. Br Med J 330 7492 (2005) 640-644
5. Calverley P.M. The role of corticosteroids in chronic obstructive pulmonary disease. Semin Respir Critical Care Med 26 2 (2005) 235-245
6. Sin D.D., Wu L., Anderson J.A., Anthonisen N.R., Buist A.S., Burge P.S., et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 60 12 (2005) 992-997
7. Kesten S., Flanders J., Serby C.W., and Witek T.J. Compliance with tiotropium, a once daily dry powder inhaled bronchodilator, in one year COPD trials. Chest 118 (2000) 191S-192S
8. Rand C.S., Nides M., Cowles M.K., Wise R.A., and Connett J. Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group. Am J Respir Critical Care Med 152 2 (1995) 580-588
9. van Grunsven P.M., van Schayck C.P., van Deuveren M., van Herwaarden C.L., Akkermans R.P., and van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the detection, intervention, and monitoring program of COPD and asthma (DIMCA) study. J Asthma 37 3 (2000) 225-234
10. Bender B.G., Pedan A., and Varasteh L.T. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol 118 4 (2006) 899-904
11. Breekveldt-Postma N.S., Gerrits C.M., Lammers J.W., Raaijmakers J.A., and Herings R.M. Persistence with inhaled corticosteroid therapy in daily practice. Respir Med 98 8 (2004) 752-759
12. Krigsman K., Nilsson J.L., and Ring L. Refill adherence for patients with asthma and COPD: comparison of a pharmacy record database with manually collected repeat prescriptions. Pharmacoepidemiology Drug Saf 28 (2006)
13. Cochrane G.M., Horne R., and Chanez P. Compliance in asthma. Respir Med 93 11 (1999) 763-769
14. George J., Kong D.C., Thoman R., and Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 128 5 (2005) 3198-3204
15. Olin J.L. Tiotropium: an inhaled anticholinergic for chronic obstructive pulmonary disease. Am J Health Syst Pharm 62 12 (2005) 1263-1269
16. Gross N.J. Tiotropium bromide. Chest 126 6 (2004) 1946-1953
17. Durham M.C. Tiotropium (Spiriva): a once-daily inhaled anticholinergic medication for chronic obstructive pulmonary disease. Proc (Baylor Univ Med Cent) 17 3 (2004) 366-373
18. Littner M.R., Ilowite J.S., Tashkin D.P., Friedman M., Serby C.W., Menjoge S.S., et al. Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Critical Care Med 161 4 Pt 1 (2000) 1136-1142
19. Koumis T., and Samuel S. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Clin Ther 27 4 (2005) 377-392
20. Benner J.S., Glynn R.J., Mogun H., Neumann P.J., Weinstein M.C., and Avorn J. Long-term persistence in use of statin therapy in elderly patients. J Am Med Assoc 288 4 (2002) 455-461
21. Suissa S., Ernst P., Benayoun S., Baltzan M., and Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343 5 (2000) 332-336
22. Blais L., Ernst P., Boivin J.F., and Suissa S. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Critical Care Med 158 1 (1998) 126-132
23. Von Korff M., Wagner E.H., and Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 45 2 (1992) 197-203
24. Hanley J.A., Negassa A., Edwardes M.D., and Forrester J.E. Statistical analysis of correlated data using generalized estimating equations: an orientation. Am J Epidemiol 157 4 (2003) 364-375
25. Claxton A.J., Cramer J., and Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 23 8 (2001) 1296-1310
26. Hilleman DE. New treatment options in COPD. J Manag Care Pharm. 2005;11(6 Suppl A):S12-9 [quiz S20-2].
27. Saberi F., and O'Donnell D.E. The role of tiotropium bromide, a long-acting anticholinergic bronchodilator, in the management of COPD. Treatments Respir Med 4 4 (2005) 275-281
28. Oostenbrink J.B., Rutten-van Molken M.P., Al M.J., Van Noord J.A., and Vincken W. One-year cost-effectiveness of tiotropium versus ipratropium to treat chronic obstructive pulmonary disease. Eur Respir J 23 2 (2004) 241-249
29. van Noord J.A., Bantje T.A., Eland M.E., Korducki L., and Cornelissen P.J. A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease. The Dutch Tiotropium Study Group. Thorax. 55 4 (2000) 289-294
30. Tashkin D.P., and Cooper C.B. The role of long-acting bronchodilators in the management of stable COPD. Chest 125 1 (2004) 249-259
31. Petri H., and Urquhart J. Channeling bias in the interpretation of drug effects. Stat Med 10 4 (1991) 577-581